Cours Pain Therapeutics, Inc. Nasdaq
Actions
US69562K5065
Recherche biotechnologique et médicale
CA 2024 * | - | CA 2025 * | 150 M 136 M | Capitalisation | 913 M 827 M |
---|---|---|---|---|---|
Résultat net 2024 * | -96 M -86,97 M | Résultat net 2025 * | - 0 | VE / CA 2024 * | - |
Trésorerie nette 2024 * | - 0 | Trésorerie nette 2025 * | - 0 | VE / CA 2025 * | 6,09 x |
PER 2024 * |
-9,84
x | PER 2025 * |
-44,4
x | Employés | - |
Rendement 2024 * |
-
| Rendement 2025 * |
-
| Flottant | 92,66% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 01/05/98 |
Eric Schoen
DFI | Director of Finance/CFO | 55 | 01/10/18 |
James Kupiec
CTO | Chief Tech/Sci/R&D Officer | - | 04/01/21 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Remi Barbier
CEO | Chief Executive Officer | 64 | 01/05/98 |
Robert Gussin
BRD | Director/Board Member | 86 | 01/03/03 |
Patrick Scannon
BRD | Director/Board Member | 76 | 07/12/07 |
Varia. 1 janv. | Capi. | |
---|---|---|
+2,97% | 108 Md | |
+10,21% | 104 Md | |
+2,27% | 22,33 Md | |
-12,77% | 22,19 Md | |
-7,05% | 18,69 Md | |
-37,64% | 17,74 Md | |
-6,50% | 17,64 Md | |
+6,00% | 14,05 Md | |
+37,20% | 12,51 Md |